Volcano Corporation Pays Up to $42.1 Million for Crux Biomedical
12/3/2012 7:38:37 AM
More...
|
FDA Clears First Ever Bi-directionally Retrievable Vena Cava Filter From Crux Biomedical
7/18/2012 8:14:38 AM
More...
|
Crux Biomedical’s Vena Cava Filter Presented at Society Of Interventional Radiology Meeting: 98% Success Rate Shown in Trial to Prevent Recurrent Pulmonary Embolism
3/26/2012 8:23:36 AM
More...
|
Crux Biomedical's IVC Filter Receives CE Mark Approval
1/23/2012 8:20:18 AM
More...
|
Crux Biomedical Names Randy Lindholm Chairman of its Board of Directors
9/29/2011 5:44:37 AM
More...
|
Crux Biomedical Successfully Completes $12 Million Funding for Advanced Filter for PE Prevention
6/7/2011 8:07:42 AM
More...
|
R. Lindholm Named to Crux Biomedical Board
3/15/2011 8:24:51 AM
More...
|
Crux Biomedical Named One of Top 50 Companies to Watch
7/13/2010 10:21:39 AM
More...
|
Crux Biomedical Enrolls First Patient in Its Retrieve 2 U.S. Pivotal Trial
7/7/2010 11:29:22 AM
More...
|
Crux Biomedical Raises $8 Million in Series B
1/22/2009 6:59:54 AM
More...
|
|